In this piece for EJCMOtv Dr Rafael Rosell and Dr Niki Karachaliou review literature on tyrosine kinase inhibitor resistant non-small cell lung cancer and minimally invasive techniques for performing rebiopsies, such as EBUS, which could be crucial in the development of new therapies for EGFR mutated, TKI-resistant NSCLC.
 
READ FULL ARTICLE